Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 15/20 | 0.56 |
| ▸ | GLP1R | P43220 | 3/20 | 0.55 |
| ▸ | GCGR | P47871 | 1/20 | 0.54 |
| ▸ | GIPR | P48546 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30398271 | 1.00 | ERAP2 (0.56) | ERAP2KISS1RGLP1RGCGRGIPR | |
| SCHEMBL29664866 | 0.93 | GLP1R (0.59) | KISS1RGLP1RGCGRGIPR | |
| SCHEMBL30204843 | 0.93 | GLP1R (0.55) | ERAP2KISS1RGLP1RGCGRGIPR | |
| SCHEMBL28081101 | 0.92 | GLP1R (0.58) | ERAP2GLP1RGCGRGIPR | |
| SCHEMBL30973988 | 0.90 | IL23R (0.55) | KISS1RGLP1RGCGRGIPR | |
| SCHEMBL29855839 | 0.89 | ERAP2 (0.60) | ERAP2KISS1RGLP1R | |
| SCHEMBL31182787 | 0.89 | GLP1R (0.65) | KISS1RGLP1RGCGRGIPR | |
| SCHEMBL31632761 | 0.89 | ERAP2 (0.61) | ERAP2KISS1R | |
| SCHEMBL28081223 | 0.89 | ERAP2 (0.58) | ERAP2KISS1RGLP1RGCGRGIPR | |
| SCHEMBL30167097 | 0.88 | GLP1R (0.62) | KISS1RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260090957-A1 | Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness | DRESDNER JR KARL P (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090957-A1 | Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness | QPCT, SLC38A7, QPCTL | ERAP2 825/4885KISS1R 1209/4885GLP1R 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.